ArticleiScience2021

Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice.

Tal Noy-Porat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.